LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 89.57 | 84.90 | 7660 | 7494 | 1.0221 | 1.0068 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 89.57 | 84.90 | 381 | 7494 | 0.0508 | 0.2615 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 89.57 | 84.90 | 8852 | 7494 | 1.1811 | 1.0522 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 91.27 | 84.90 | 194 | 7420 | 0.0261 | 0.1367 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 91.27 | 84.90 | 7743 | 7420 | 1.0435 | 1.0132 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 91.27 | 84.90 | 383 | 7420 | 0.0516 | 0.2631 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 91.27 | 84.90 | 8993 | 7420 | 1.2120 | 1.0605 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 92.98 | 84.90 | 206 | 7257 | 0.0284 | 0.1481 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 92.98 | 84.90 | 7900 | 7257 | 1.0885 | 1.0266 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 92.98 | 84.90 | 376 | 7257 | 0.0518 | 0.2610 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 92.98 | 84.90 | 9158 | 7257 | 1.2618 | 1.0738 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 94.68 | 84.90 | 163 | 7000 | 0.0233 | 0.1079 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 94.68 | 84.90 | 8051 | 7000 | 1.1501 | 1.0444 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 94.68 | 84.90 | 320 | 7000 | 0.0457 | 0.2318 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 94.68 | 84.90 | 9363 | 7000 | 1.3375 | 1.0935 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 2.66 | 84.90 | 602 | 285 | 2.1068 | 2.0610 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 2.66 | 84.90 | 596 | 285 | 2.0858 | 2.0435 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 4.36 | 84.90 | 668 | 322 | 2.0709 | 1.9187 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 4.36 | 84.90 | 677 | 322 | 2.0988 | 1.9391 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 6.06 | 84.90 | 729 | 365 | 1.9948 | 1.7761 | MN20160318_Q02 | K22 |